ProKidney Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Bruce Culleton

Chief executive officer

US$9.0m

Total compensation

CEO salary percentage2.7%
CEO tenureless than a year
CEO ownershipn/a
Management average tenure1.3yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

Here's Why We're Not Too Worried About ProKidney's (NASDAQ:PROK) Cash Burn Situation

Nov 17
Here's Why We're Not Too Worried About ProKidney's (NASDAQ:PROK) Cash Burn Situation

ProKidney (NASDAQ:PROK) Is In A Strong Position To Grow Its Business

Mar 14
ProKidney (NASDAQ:PROK) Is In A Strong Position To Grow Its Business

ProKidney reports Q2 2022 results

Aug 11

CEO Compensation Analysis

How has Bruce Culleton's remuneration changed compared to ProKidney's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$9mUS$245k

-US$35m

Compensation vs Market: Bruce's total compensation ($USD9.00M) is above average for companies of similar size in the US market ($USD2.40M).

Compensation vs Earnings: Insufficient data to compare Bruce's compensation with company performance.


CEO

Bruce Culleton (55 yo)

less than a year

Tenure

US$9,003,399

Compensation

Dr. Bruce Culleton, M.D., is Chief Executive Officer and Director at ProKidney Corp. since November 15, 2023. He was Executive Vice President of Clinical Development & Commercialization of ProKidney Corp....


Leadership Team

NamePositionTenureCompensationOwnership
Bruce Culleton
CEO & Directorless than a yearUS$9.00mno data
Timothy Bertram
Founderno dataUS$7.58m0%
$ 0
James Coulston
Chief Financial Officer2.3yrsUS$2.29mno data
Todd Girolamo
Chief Legal Officer & Secretary2.2yrsUS$2.30m0.13%
$ 653.3k
Mary Weger
Chief People Officerno datano datano data
Joseph Stavas
Senior VP of Interventional Procedures & Patient Safety4.6yrsno datano data
Darin Weber
Chief Reg. Off3.7yrsno data0.24%
$ 1.2m
Nikhil Pereira-Kamath
Chief Business Officerless than a yearno datano data
Richard Williams
Senior Vice President of Information Technology1.3yrsno datano data
Aparna Sahoo
VP & Head of Global Clinical Development1.3yrsno datano data
Emily Butler
Senior VP of Biometricless than a yearno datano data
Lucio Tozzi
Senior Vice President of Global Clinical Operationsless than a yearno datano data

1.3yrs

Average Tenure

58yo

Average Age

Experienced Management: PROK's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Bruce Culleton
CEO & Directorless than a yearUS$9.00mno data
William Doyle
Independent Director2.3yrsUS$413.10kno data
John M. Maraganore
Independent Director2yrsUS$420.10kno data
Jennifer Fox
Independent Director1.8yrsUS$749.64k0.067%
$ 343.9k
Brian J. Pereira
Independent Director2.3yrsUS$421.10kno data
Alan Lotvin
Independent Director2.3yrsUS$423.60kno data
Uma Sinha
Independent Directorno dataUS$410.60k0.047%
$ 239.2k
Pablo Legorreta
Chairman of the Boardno dataUS$434.10kno data
Jose Jimenez Santos
Independent Directorno dataUS$404.60kno data

2.2yrs

Average Tenure

61yo

Average Age

Experienced Board: PROK's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.